| Financial Year |
March 31 2023 |
| Monetary Funds |
99,657,065.59 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
24,374,608.40 |
| Accounts Receivable |
139,366,163.20 |
| Advances to Suppliers |
57,883,048.78 |
| Other Receivables |
9,551,753.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,278,557.49 |
| Total Current Assets |
337,111,197.04 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
28,206,046.48 |
| Investment Properties |
6,119,824.70 |
| Fixed Assetes |
1,101,183.52 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,220,914.48 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
329,815.16 |
| Deferred Income Tax Assets |
18,448,895.02 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
82,225,755.38 |
| Total Assets |
419,336,952.42 |
| Short-Term Loans |
21,374,608.40 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
23,705,436.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,881,272.50 |
| Taxes Payable |
1,664,163.75 |
| Interest Payable |
7,022,730.91 |
| Dividend Payable |
-- |
| Other payables |
13,500,371.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,206,521.10 |
| Other Current Liabilities |
4,480,428.14 |
| Sub-Total of Current Liabilities |
79,200,710.59 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
25,649,239.26 |
| Total Liabilities |
104,849,949.85 |
| Paid-In Capital(Or Share Stock) |
230,307,175.00 |
| Capital Surplus |
138,384,069.91 |
| Surplus Reserve |
-- |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-88,659,636.87 |
| Minority Stockholder's Interest |
34,436,512.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
280,050,489.68 |
| Owner's Equity（Stockholder's Equity） |
314,487,002.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
419,336,952.42 |
